FDG-PET/CT in lymphoma

Indian Journal of Radiology and Imaging

Madhavi Tripathi¹  Maria M D′souza²  Abhinav Jaimini²  Rajnish Sharma²  Anupam Mondal²  Abhishek Bansal²  Rajendra Prashad Tripathi² 

[1] Department of Nuclear Medicine, AIIMS, New Delhi, India;Department of PET Imaging, Institute of Nuclear Medicine and Allied Sciences, Brig. SK Majumdar Marg, New Delhi, India;

关键词: imaging;    lymphoma;    pet/ct;   

DOI  :  10.1055/s-0041-1734382

来源: DOAJ

【 摘 要 】

Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune system or from their precursors. 18F-fludeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) is now the cornerstone of staging procedures in the state-of-the-art management of Hodgkin′s disease and aggressive non-Hodgkin′s lymphoma. It plays an important role in staging, restaging, prognostication, planning appropriate treatment strategies, monitoring therapy, and detecting recurrence. However, its role in indolent lymphomas is still unclear and calls for further investigational trials. The protean PET/CT manifestations of lymphoma necessitate a familiarity with the spectrum of imaging findings to enable accurate diagnosis. A meticulous evaluation of PET/CT findings, an understanding of its role in the management of lymphomas, and knowledge of its limitations are mandatory for the optimal utilization of this technique.

【 授权许可】

Unknown